Related Experiment Video
Updated: May 28, 2026

09:54
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
Tuberculosis in children: New diagnostic blood tests
Paediatrics & Child Health
|October 4, 2011
Summary
Interferon-gamma-release assays offer improved specificity over the tuberculin skin test for diagnosing latent tuberculosis infection (LTBI). These blood tests may enhance diagnosis in specific patient groups when used alongside the TST.
Area of Science:
- Immunology
- Infectious Diseases
- Clinical Diagnostics
Background:
- The tuberculin skin test (TST) for latent tuberculosis infection (LTBI) has limitations.
- Interferon-gamma-release assays (IGRAs) were developed as alternatives to TST.
- Two IGRAs are available in Canada: QuantiFERON-TB Gold In-Tube and T.SPOT-TB.
Purpose of the Study:
- To summarize IGRAs, their limitations, and clinical applications.
- To evaluate the role of IGRAs in diagnosing LTBI, particularly in pediatric populations.
- To compare the specificity and sensitivity of IGRAs versus TST.
Main Methods:
- Review of existing literature on IGRAs and TST.
- Analysis of performance data for QuantiFERON-TB Gold In-Tube and T.SPOT-TB.
- Assessment of diagnostic utility in various patient cohorts, including immunocompromised individuals and children.
Main Results:
- IGRAs demonstrate higher specificity compared to TST.
- Limited pediatric data exists for IGRA evaluation.
- IGRAs may be beneficial for TST-positive individuals at low LTBI risk.
- Combined IGRA and TST use may improve sensitivity in specific populations.
Conclusions:
- IGRAs represent a valuable diagnostic tool for LTBI, offering improved specificity.
- Further research is needed to address limitations, particularly in pediatric applications.
- IGRAs can complement TST, especially in high-risk or immunocompromised individuals.
Related Concept Videos
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Serum Laboratory Studies, Stool Test, Breath Test
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
